NervGen Pharma Announces Closing of US$10 Million Non-Brokered Private Placement to Support ...

NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) ("NervGen" or the "Company"), a clinical-stage biopharmaceutical company ...

KBRA Assigns Preliminary Ratings to GCAT 2025-NQM7 Trust

KBRA assigns preliminary ratings to eight classes of mortgage pass-through notes from GCAT 2025-NQM7 Trust, a $299.0 million non-prime RMBS transaction. The underlying collateral, comprising 550 ...